HomeLexicon

Lexicon

  • No.156, Mar.9.2018

  • G1/G2 Rule

    G1/G2ルール
In the FY2018 drug price revision in April 2018, the MHLW is drastically revamping its re-pricing scheme for long-listed products (LLPs) (長期収載品; choki shusai hin), or off-patent brand-name drugs, as it hopes to further accelerate Japan’s shift from LLPs to ...

(LOG IN FOR FULL STORY)

Lexicon Latestmore

G1/G2 Rule G1/G2ルール
New PMP Criteria 新薬創出加算の新要件
Cost Calculation Method 原価計算方式
Sakigake Designation Scheme 先駆け審査指定制度
Special expansion re-pricing (Huge-seller re-pricing) 特例拡大再算定(巨額再算定)
Market expansion re-pricing 市場拡大再算定
3 price-band (bracket) grouping rule 3価格帯ルール
Price Maintenance Premium 新薬創出加算
Z2 Rule Z2(ゼットツー)
Japan Agency for Medical Research and Development (AMED) 日本医療研究開発機構

News Calendar